MCMCB Pro
J1434

J1434Injection, fosaprepitant (focinvez), 1 mg

HCPCSActiveBETOS O1E

J1434 is a HCPCS Level II code for injection, fosaprepitant (focinvez), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J1434 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
150 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
150 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
150 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J1434

Long descriptor
Injection, fosaprepitant (focinvez), 1 mg

The official wording. This is what the code means.

Short descriptor
Inj, focinvez, 1mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
April 1, 2024

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J1434

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1434 is not quite right, the correct code is very often within a few positions of it.

  • J1412Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
  • J1413Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
  • J1414Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
  • J1426Injection, casimersen, 10 mg
  • J1427Injection, viltolarsen, 10 mg
  • J1428Injection, eteplirsen, 10 mg
  • J1429Injection, golodirsen, 10 mg
  • J1430Injection, ethanolamine oleate, 100 mg
  • J1435Injection, estrone, per 1 mg
  • J1436Injection, etidronate disodium, per 300 mg
  • J1437Injection, ferric derisomaltose, 10 mg
  • J1438Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J1439Injection, ferric carboxymaltose, 1 mg
  • J1440Fecal microbiota, live - jslm, 1 ml
  • J1442Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
  • J1443Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of ironterminated

Questions about J1434

What is HCPCS code J1434?

J1434 is a HCPCS Level II code for injection, fosaprepitant (focinvez), 1 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J1434?

The CMS HCPCS file marks J1434 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J1434 paid under the physician fee schedule?

J1434 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026